查看购物车
  • Traditional Chinese
  • English
  • Japanese
定序试剂市场规模、份额及成长分析（按试剂类型、定序技术、应用、最终用户及地区划分）－2025-2032年产业预测
市场调查报告书
商品编码
1865221

定序试剂市场规模、份额及成长分析（按试剂类型、定序技术、应用、最终用户及地区划分）－2025-2032年产业预测

Sequencing Reagents Market Size, Share, and Growth Analysis, By Reagent Type, By Sequencing Technology (Next-Generation Sequencing, Sanger Sequencing), By Application, By End-User, By Region - Industry Forecast 2025-2032
出版日期: | 出版商: SkyQuest | 英文 174 Pages | 商品交期: 3-5个工作天内

价格
简介目录

预计到 2023 年，全球定序试剂市场规模将达到 82 亿美元，到 2024 年将成长至 96.6 亿美元，到 2032 年将成长至 358.2 亿美元，预测期（2025-2032 年）的复合年增长率为 17.8%。

全球定序定序市场预计将迎来显着成长，这主要得益于次世代定序(NGS) 技术的日益普及和精准医疗需求的不断增长。随着医疗专业人员越来越多地利用基因组数据进行包括肿瘤学和罕见疾病研究在内的各种应用，定序试剂的需求预计将大幅提升。此外，基因测序在农业、环境监测和微生物组研究等领域的广泛应用也创造了新的机会。技术进步正在降低定序成本并提高其可及性，从而进一步提升供应商的收入前景。然而，高成本、数据分析复杂、伦理问题以及不同平台之间的相容性问题等挑战，可能会在短期内阻碍市场渗透。

全球定序试剂市场驱动因素

全球定序试剂市场的主要驱动因素之一是对个人化医疗日益增长的需求，而个人化医疗高度依赖基因组数据来客製化治疗方案。随着医疗保健向精准医疗发展，对准确且高效的定序技术的需求不断增长，推动了定序试剂的进步。此外，遗传疾病的日益普遍以及定序技术在肿瘤学、药物基因组学和感染疾病控制等领域的广泛应用，也进一步推动了市场发展。这些因素，加上持续不断的研发投入，不断提升定序试剂的性能和可近性，促进了其在全球的广泛应用。

限制全球定序试剂市场发展的因素

全球定序试剂市场的主要限制因素之一是先进定序技术及其试剂本身的高成本。研究和临床应用所需的大量资金投入可能会阻碍小型实验室和机构采用这些技术。此外，严格的监管要求以及有效使用定序试剂所需的专业人员也进一步增加了这些机构进入市场的难度。这种高准入门槛可能会限制创新和取得尖端定序解决方案，最终减缓整体市场成长，并阻碍其在各种研究和临床环境中的广泛应用。

全球定序试剂市场趋势

全球定序试剂市场正呈现单细胞和空间基因组学应用日益增长的显着趋势。试剂产业的企业正致力于条码化学技术的进步和扩增效率的提升，同时优先考虑污染控制，以满足研究人员的特殊需求。这项转变的驱动力在于对超灵敏、低起始量试剂的需求不断增长，这些试剂能够检测细微的基因表现和突变，从而推动个人化医疗和疾病研究的突破。因此，市场呈现成长态势，定序技术的创新正在塑造其未来的发展模式。

目录

介绍

  • 调查目标
  • 调查范围
  • 定义

调查方法

  • 资讯收集
  • 二手资料和一手资料方法
  • 市场规模预测
  • 市场假设与限制

执行摘要

  • 全球市场展望
  • 供需趋势分析
  • 细分市场机会分析

市场动态与展望

  • 市场概览
  • 市场规模
  • 市场动态
    • 驱动因素和机会
    • 限制与挑战
  • 波特分析

关键市场考察

  • 关键成功因素
  • 竞争程度
  • 关键投资机会
  • 市场生态系统
  • 市场吸引力指数（2024）
  • PESTEL 分析
  • 总体经济指标
  • 价值链分析
  • 定价分析
  • 技术评估
  • 监管环境

按试剂类型定序试剂市场规模及复合年增长率（2025-2032 年）

  • 市场概览
  • 样品製备套件
  • 模板套件
  • 控制和品质保证套件
  • 定序套件
  • 其他（富集试剂套件、索引/条码试剂）

依定定序技术分類的定序试剂市场规模及复合年增长率（2025-2032 年）

  • 市场概览
  • 次世代定序（NGS）
  • 桑格定序
  • 第三代定序（TGS）/长读长定序

依应用领域定序试剂市场规模及复合年增长率（2025-2032 年）

  • 市场概览
  • 肿瘤学/液态生物检体
  • 生殖医学/产前检查
  • 临床诊断
  • 研究/学术基因组学
  • 农业、法医学等。

依最终用户定序试剂市场规模及复合年增长率（2025-2032 年）

  • 市场概览
  • 医院和临床实验室
  • 製药和生物技术公司
  • 学术和研究机构
  • 受託研究机构（CRO）

定序试剂市场规模及复合年增长率（2025-2032）

  • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 德国
    • 西班牙
    • 法国
    • 英国
    • 义大利
    • 其他欧洲地区
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 亚太其他地区
  • 拉丁美洲
    • 巴西
    • 其他拉丁美洲地区
  • 中东和非洲
    • 海湾合作委员会国家
    • 南非
    • 其他中东和非洲地区

竞争资讯

  • 前五大公司对比
  • 主要企业的市场定位（2024 年）
  • 主要市场参与者所采取的策略
  • 近期市场趋势
  • 公司市占率分析（2024 年）
  • 主要企业简介
    • 公司详情
    • 产品系列分析
    • 依业务板块进行公司股票分析
    • 2022-2024年营收年比比较

主要企业简介

  • Illumina, Inc.
  • Thermo Fisher Scientific Inc.
  • QIAGEN NV
  • Oxford Nanopore Technologies plc
  • Pacific Biosciences of California, Inc.
  • F. Hoffmann La Roche AG
  • Agilent Technologies, Inc.
  • Takara Bio Inc.
  • BD（Becton, Dickinson and Company）
  • Meridian Bioscience Inc.
  • Fluidigm Corporation
  • BGI Genomics
  • Illumina Cambridge Ltd
  • Myriad Genetics, Inc.
  • ArcherDX, Inc.
  • Eurofins Scientific SE
  • PerkinElmer, Inc.
  • Bio Rad Laboratories, Inc.
  • Takara Holdings Inc.
  • Beijing Genomics Institute（BGI）

结论与建议

简介目录
Product Code: SQMIG35H2383

Global Sequencing Reagents Market size was valued at USD 8.2 billion in 2023 and is poised to grow from USD 9.66 billion in 2024 to USD 35.82 billion by 2032, growing at a CAGR of 17.8% during the forecast period (2025-2032).

The global sequencing reagents market is poised for significant growth, driven by the increasing adoption of next-generation sequencing (NGS) technologies and the rising demand for precision medicine. As healthcare professionals increasingly utilize genomic data for various applications, including oncology and rare disease research, the demand for sequencing reagents is expected to surge. Moreover, the expanding use of genomic sequencing in agriculture, environmental monitoring, and microbiome studies presents new opportunities. Advances in technology are also leading to reduced sequencing costs and improved accessibility, further enhancing revenue prospects for providers. However, challenges such as high reagent costs, complex data analysis, ethical concerns, and compatibility issues with different platforms may hinder market penetration in the foreseeable future.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Sequencing Reagents market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Sequencing Reagents Market Segments Analysis

Global Sequencing Reagents Market is segmented by Reagent Type, Sequencing Technology, Application, End-User and region. Based on Reagent Type, the market is segmented into Library Preparation Kits, Template Kits, Control & Quality Assurance Kits, Sequencing Kits and Others (enrichment kits, indexing/barcoding reagents). Based on Sequencing Technology, the market is segmented into Next-Generation Sequencing (NGS), Sanger Sequencing and Third-Generation Sequencing (TGS) / Long-Read Sequencing. Based on Application, the market is segmented into Oncology & Liquid Biopsy, Reproductive Health / Prenatal Testing, Clinical Diagnostics, Research / Academic Genomics and Agriculture, Forensics & Others. Based on End-User, the market is segmented into Hospitals & Clinical Laboratories, Pharmaceutical & Biotechnology Companies, Academic & Research Institutes and Contract Research Organizations (CROs). Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Sequencing Reagents Market

One of the key market drivers for the global sequencing reagents market is the increasing demand for personalized medicine, which relies heavily on genomic data for tailored treatment approaches. As healthcare shifts towards precision medicine, the need for accurate and efficient sequencing technologies grows, prompting advancements in sequencing reagents. Additionally, the rising prevalence of genetic disorders and the expansion of applications in areas such as oncology, pharmacogenomics, and infectious disease management further fuel the market. These factors, combined with ongoing research and development initiatives, continue to enhance the capabilities and accessibility of sequencing reagents, driving their widespread adoption globally.

Restraints in the Global Sequencing Reagents Market

One significant market restraint in the global sequencing reagents market is the high cost associated with advanced sequencing technologies and the reagents themselves. The substantial financial investment required for research and clinical applications can deter smaller laboratories and institutions from adopting these technologies. Additionally, stringent regulatory requirements and the necessity for specialized personnel to effectively utilize sequencing reagents further complicate market entry for these entities. This high barrier to entry may limit innovation and access to cutting-edge sequencing solutions, ultimately slowing down the overall growth of the market and hindering widespread implementation across diverse research and clinical settings.

Market Trends of the Global Sequencing Reagents Market

The Global Sequencing Reagents market is witnessing a significant trend towards the expansion of single-cell and spatial genomics applications. Companies in the reagents sector are increasingly focusing on advancing barcoding chemistries and enhancing amplification efficiency, while also prioritizing contamination control to cater to the specialized demands of researchers. This shift is driven by the rising necessity for ultra-sensitive and low-input reagents capable of detecting subtle gene expressions and mutations, thereby enabling breakthroughs in personalized medicine and disease research. As a result, the market is poised for growth, with innovations in sequencing technologies shaping its future landscape.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers & Opportunities
    • Restraints & Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2024
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis
  • Technology Assessment
  • Regulatory Landscape

Global Sequencing Reagents Market Size by Reagent Type & CAGR (2025-2032)

  • Market Overview
  • Library Preparation Kits
  • Template Kits
  • Control & Quality Assurance Kits
  • Sequencing Kits
  • Others (enrichment kits, indexing/barcoding reagents)

Global Sequencing Reagents Market Size by Sequencing Technology & CAGR (2025-2032)

  • Market Overview
  • Next-Generation Sequencing (NGS)
  • Sanger Sequencing
  • Third-Generation Sequencing (TGS) / Long-Read Sequencing

Global Sequencing Reagents Market Size by Application & CAGR (2025-2032)

  • Market Overview
  • Oncology & Liquid Biopsy
  • Reproductive Health / Prenatal Testing
  • Clinical Diagnostics
  • Research / Academic Genomics
  • Agriculture, Forensics & Others

Global Sequencing Reagents Market Size by End-User & CAGR (2025-2032)

  • Market Overview
  • Hospitals & Clinical Laboratories
  • Pharmaceutical & Biotechnology Companies
  • Academic & Research Institutes
  • Contract Research Organizations (CROs)

Global Sequencing Reagents Market Size & CAGR (2025-2032)

  • North America (Reagent Type, Sequencing Technology, Application, End-User)
    • US
    • Canada
  • Europe (Reagent Type, Sequencing Technology, Application, End-User)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Reagent Type, Sequencing Technology, Application, End-User)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Reagent Type, Sequencing Technology, Application, End-User)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Reagent Type, Sequencing Technology, Application, End-User)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2024
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2024
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

  • Illumina, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Thermo Fisher Scientific Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • QIAGEN N.V.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Oxford Nanopore Technologies plc
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Pacific Biosciences of California, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • F. Hoffmann La Roche AG
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Agilent Technologies, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Takara Bio Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • BD (Becton, Dickinson and Company)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Meridian Bioscience Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Fluidigm Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • BGI Genomics
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Illumina Cambridge Ltd
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Myriad Genetics, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • ArcherDX, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Eurofins Scientific SE
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • PerkinElmer, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bio Rad Laboratories, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Takara Holdings Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Beijing Genomics Institute (BGI)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations